Mylan’s Generic Advair Approval Showcases US FDA Efforts To Boost Complex Products

Commissioner Gottlieb previews actions agency intends to take in 2019 to smooth the regulatory and scientific pathway for generics of complex drugs, including draft guidance with recommendations on establishing active ingredient sameness.